Vycor Medical (VYCO) Net Margin (2010 - 2026)
Vycor Medical (VYCO) reported Net Margin of 30.98% for Q1 2026, up 1502.0% year-over-year from 1.93% in Q1 2025, and down 106.06% quarter-over-quarter from 15.04% in Q4 2025.
Vycor Medical (VYCO) Net Margin (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Net Margin data on file, last reported at 30.98% in Q1 2026.
- Net Margin for Q1 2026 came in at 30.98%, up 1502.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 17.93% (up 809.0% YoY), and the FY2025 annual result was 21.29%, up 586.0% from the prior year.
- Net Margin fell to 30.98% in Q1 2026 per VYCO's latest filing, from 15.04% in the prior quarter.
- Over five years, Net Margin peaked at 14.17% in Q2 2023 and troughed at 89.36% in Q3 2022.
- A 5-year average of 35.42% and a median of 30.98% in 2026 frame the typical range for Net Margin.
- On a YoY basis, Net Margin climbed as much as 6154 bps in 2022 and fell as far as 4164 bps in 2022.
- A 5-year view of Net Margin shows it stood at 42.96% in 2022, then gained by 30 bps to 30.19% in 2023, then surged by 95 bps to 1.48% in 2024, then plunged by 916 bps to 15.04% in 2025, then tumbled by 106 bps to 30.98% in 2026.
- Business Quant data shows VYCO's Net Margin at 30.98% in Q1 2026, 15.04% in Q4 2025, and 30.61% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Vycor Medical | - | - | 375,153.00 | -30.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.98% |
| Dec 31, 2025 | -15.04% |
| Sep 30, 2025 | -30.61% |
| Jun 30, 2025 | 4.81% |
| Mar 31, 2025 | -46.00% |
| Dec 31, 2024 | -1.48% |
| Sep 30, 2024 | -56.80% |
| Jun 30, 2024 | -2.47% |
| Mar 31, 2024 | -57.21% |
| Dec 31, 2023 | -30.19% |
| Sep 30, 2023 | -69.38% |
| Jun 30, 2023 | 14.17% |
| Mar 31, 2023 | -43.03% |
| Dec 31, 2022 | -42.96% |
| Sep 30, 2022 | -89.36% |
| Jun 30, 2022 | -30.19% |
| Mar 31, 2022 | -75.43% |
| Dec 31, 2021 | -68.34% |
| Sep 30, 2021 | -47.73% |
| Jun 30, 2021 | -1.91% |